Arvinas (ARVN) Invested Capital (2017 - 2023)
Arvinas' (ARVN) quarterly Invested Capital came in at $200000.0 in Q3 2023, up 100.0% quarter-over-quarter from $100000.0 in Q2 2023.
Arvinas (ARVN) Invested Capital (2017 - 2023) Analysis & Trends
Arvinas' Invested Capital history runs 4 years deep, the most recent figure standing at $200000.0 for Q3 2023.
- On a quarterly basis, Invested Capital changed N/A year-over-year to $200000.0 in Q3 2023; TTM through Jun 2024 was $200000.0, a 0.0% change from a year earlier, with the FY2018 full-year figure at $154461.0, down 3.02% from the prior year.
- Invested Capital climbed to $200000.0 in Q3 2023 per ARVN's latest filing, from $100000.0 in the prior quarter.
- Across five years, Invested Capital topped out at $200000.0 in Q3 2023 and bottomed at $71499.0 in Q2 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 110.96 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 116.14 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Arvinas | 519.68 Mn | -95.22 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | 200,000.00 |
| Jun 30, 2023 | 100,000.00 |
| Mar 31, 2023 | 100,000.00 |
| Jun 30, 2019 | 71,499.00 |
| Mar 31, 2019 | 113,410.00 |
| Dec 31, 2018 | 154,461.00 |
| Sep 30, 2018 | 194,669.00 |
| Dec 31, 2017 | 159,265.00 |